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A young woman with placement of a dual-chamber implantable cardioverter-deﬁbrillator (ICD) and a
history of prior cardiac arrest due to congenital long QT syndrome presented with deﬁbrillation caused
by a ventricular ﬁbrillation arrest. Routine device interrogation revealed signiﬁcant lead dysfunction.
During device revision, breaches were detected in the insulation of both leads within the pre-pectoral
pocket and an ‘‘arc mark’’ was observed on the ICD generator casing; these ﬁndings were consistent
with a high-voltage discharge through a short circuit between the denuded right ventricular lead and
the casing. In this case, system failure was unmasked only by interrogation after appropriate device
activation, which highlights the importance of thorough evaluation after all ICD activations.
& 2012 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.1. Introduction
Implantable cardioverter-deﬁbrillators (ICDs) are indicated for
the prevention of sudden cardiac death in patients with an
inherited channelopathy and high-risk factors, such as history
of resuscitated sudden cardiac death, malignant ventricular
arrhythmias, and family history of a malignant genetic phenotype
[1,2]. With proven mortality beneﬁts in a range of patient
populations, the use of ICDs has increased dramatically over the
years, and a major concern now is the long-term reliability of ICD
systems.2. Case report
We report a case of ICD system failure in a young woman
because of a breach in the lead insulation, which was caused by
repetitive contact between the lead and the ICD generator can.
After an episode of cardiac arrest due to ventricular ﬁbrillation
(VF) at 10 years of age, the patient was diagnosed with congenital
long QT syndrome in 1997. However, even after b blockade,
another VF arrest occurred in 2000, whereby a dual-chamber
ICD was implanted (VENTAK Prizm DR 1851, Guidant Corpora-
tion) with a passive bipolar right atrial lead (Fineline II Sterox
Atrial J 4480, Guidant Corporation) and a passive dual-coil,rt Rhythm Society. Published by E
iology, Princess Alexandra
2381; fax: þ61 7 3176 7630.
(P.A. Gould).tri-lumen right ventricular pace/sense/deﬁbrillation lead with
silicone rubber insulation (Endotak Reliance 0148, Guidant Cor-
poration). In 2004, she underwent routine replacement of the
generator (VENTAK Prizm II DR 1861, Guidant Corporation).
On 5th August 2008, the patient had yet another VF arrest,
which was successfully controlled by her ICD. Device interroga-
tion revealed appropriate detection of VF, with an initial unsuc-
cessful deﬁbrillation attempt followed by a successful 31-joule
shock (Fig. 1). All lead impedances were found to be markedly
lower than the routine measurements made by the device up to
and including the day of the ICD shock (Fig. 2). Additionally, the
sensing was unchanged; the capture threshold of the atrial lead
had risen from 0.8 to 1.2 V at 0.4 ms; and the ventricular pace/
sense lead failed to capture at the maximal output. Chest radio-
graphy did not furnish any evidence of lead conductor fracture or
insulation breach (Fig. 3).
On revision of her ICD system, insulation breaches were identi-
ﬁed in the portions of both the atrial and ventricular leads within
the pre-pectoral pocket, along with a clear ‘‘arc mark’’ on the ICD
generator casing, which was consistent with a high-voltage elec-
trical discharge through a short circuit between the denuded right
ventricular lead and the casing (Fig. 4). The right atrial lead was
successfully extracted, but the extraction of the right ventricular
lead was unsuccessful. Thereafter, a new ICD system was success-
fully implanted.3. Discussion
Long-term data on ICD lead survival are disappointing with
regard to ICD lead longevity, but the conclusions are confoundedlsevier B.V. All rights reserved.
Fig. 1. Atrial bipolar, ventricular bipolar, and far-ﬁeld electrograms. (A) Induction of VF with short-coupled ventricular premature complexes in the setting of QT prolongation.
(B) Unsuccessful 31-J biphasic shock. (C) Successful 31-J biphasic shock.
Fig. 2. Implantable cardioverter-deﬁbrillator (ICD) lead function from March 2008 to August 2008. A marked reduction in the impedance of the atrial pacing lead and of
the right ventricular pace/sense/deﬁbrillation lead was seen on 6th August 2008, after the patient presented with 2 ICD discharges.
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ICD lead models studied [3,4]. In early studies, lead failure
rates have been reported to be as high as 18% at 4 years; 19%
at 5 years; and 38% at 8 years, with a coaxial lead design
highlighted as a particular risk. More recent studies have included
patients with multi-lumen ICD leads [5,6]. Kleemann and collea-
gues, for example, prospectively followed a large cohort of
patients who underwent implantation of 19 different ICD leads
between 1992 and 2005. Estimated lead survival rates at 5 and
8 years after implantation were 85% and 60%, respectively,
with the annual lead failure rate increasing with time after
implantation to reach 20% after 10 years. A younger age was
associated with a higher rate of lead failure, and female gender
was strongly associated with elevated risk [5]. Younger age and
female gender have likewise been reported as risk factors for lead
failure by other investigators, for example, Hauser and colleagues,
in their multicentre review of Medtronic Sprint Fidelis lead
failure [7].
Dysfunction may develop in any component of the ICD lead, but
a defect in lead insulation remains the most common problem [5,6].
Insulation with polyurethane, which has outstanding tensile
strength, facilitates the manufacture of leads with small diameters.
Poor biostability resulting in polymer degradation does, however,
increase the risk of insulation breaches, and most studies have
reported an association between polyurethane insulation andFig. 4. The insulation breach on the right ventricular implantable cardiover
Fig. 3. Chest radiography performed after device interrogation indicated atrial
and ventricular lead failure and before device revision; no conductor fracture or
insulation breach is apparent.insulation failure [8,9]. Silicone rubber insulation is biologically
more stable, but is more vulnerable to mechanical injury. A
particular issue with this type of insulation is longitudinal insulation
creep [10] at pressure points, such as between the clavicle and ﬁrst
rib or, as in our case, where a lead makes contact with the generator
in the pocket.
Early recognition of ICD lead malfunction is desirable to
prevent the life-threatening consequences of lead failure. Recent
reports indicate that the majority of patients with ICD lead failure
experience inappropriate ICD therapies, often as the presenting
problem [4,6]. Regular device interrogation is mandatory, but
impending lead failure commonly remains undiscovered as mea-
surements of lead impedance, sensing, and pacing threshold may
be normal even in the presence of defective insulation. Inap-
propriate electrical discharge may be the ﬁrst sign of lead failure,
and therefore, ICD deﬁbrillation events should be thoroughly
evaluated.
VENTAK Prizm 2 DR ICDs manufactured prior to 2002
were vulnerable to the development of a short circuit within
the device header assembly itself; this was because of the
deterioration of the polyimide insulation around the high-voltage
ground wire connected to the external lead [11,12]. A high-
voltage discharge has the potential to damage the components
within the ICD generator and render the case inoperable.
The problem in our case was different: the defect in the ICD lead
insulation was within the pre-pectoral ICD pocket. This exposed
the high-voltage conductor, thereby allowing the development of
an electrical short circuit between this conductor and the ICD
generator casing. Upon appropriate detection of VF, a high-
voltage electrical discharge was transmitted back to the ICD
generator casing via the short circuit created by the denuded
lead. Fortunately, the patient’s generator remained capable of
delivering a subsequent deﬁbrillation, presumably due to the
loss of contact between the lead and the ICD generator can at
that moment. Sweeney [13] in 2001 described a similar case in
which a short circuit between a denuded ICD lead (Medtronic
6932 lead) and an ICD generator (Medtronic 7271 pulse gen-
erator) within a pre-pectoral pocket was revealed by a light
ﬂash above the pocket at the time of unsuccessful deﬁbrillation
threshold testing. This event was followed by the inability to
deliver a further shock despite ongoing VF and the subsequent
ﬁnding of reduced high-voltage lead impedance. As observed in
their case, an appropriate shock unmasked an ICD lead insulation
breach.ter-deﬁbrillator (ICD) lead and the arc mark on the ICD generator can.
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